From: A new framework for evaluating the health impacts of treatment for Gaucher disease type 1
Mean or Proportion for estimation sample | Coefficient | Robust standard error | 95% CI | |
---|---|---|---|---|
DS3 Severity (vs. Mild) | ||||
Moderate | 0.381 | −0.078** | 0.037 | −0.150, −0.005 |
Marked | 0.113 | −0.122*** | 0.042 | −0.205, −0.039 |
Severe | 0.021 | −0.168** | 0.055 | −0.275, −0.061 |
Bone Pain | 0.258 | −0.098*** | 0.034 | −0.165, −0.032 |
Severe Skeletal Complications | 0.103 | 0.018 | 0.037 | −0.055, 0.090 |
Female | 0.691 | −0.049 | 0.030 | −0.108, 0.010 |
Age at Treatment Initiation | 53.9 | −0.002* | 0.001 | −0.004, 0.001 |
Constant | 0.880*** | 0.078 | 0.727, 1.033 | |
Number of Observations | 97 | |||
Number of Patients | 50 |